22 unknown. 22 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 22 | Unknown 22 |
Follow Nephritis: new trials by email Literature Review of Nephritis trials Research Report on Nephritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis Mescaline sodium enteric-coated tablets, Morte-mescaline, Glucocorticoids - Lupus Nephritis | Phase 4 | Unknown | Xiangya Hospital of Central South University | 205 | 2023-07-06 | 2023-07-06 |
| Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus Mycophenolate Mofetil, Tacrolimus, Glucocorticoid - Systemic Lupus Erythematosus, Lupus Nephritis | Phase 4 | Unknown | Chinese SLE Treatment And Research Group | 220 | 2023-07-01 | 2024-07-09 |
| Individualized Homeopathy to Reduce the Use of Antibiotics in Women With Recurrent Uncomplicated Urinary Tract Infections One out of 140 predefined homeopathic medical products (HMP) in potency C200 or C1000, - Urinary Tract Infection Chronic | Phase 4 | Unknown | Technical University of Munich | 220 | 2023-03-15 | 2024-11-08 |
| Treatment With Metformin in Chinese Children With Alport Syndrome Metformin, Placebo - Alport Syndrome, Metformin | Phase 4 | Unknown | Peking University First Hospital | 78 | 2023-01-03 | 2022-12-19 |
| MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN Cyclophosphamide, Mycophenolate Mofetil - Mycophenolate Mofetil, Cyclophosphamide | Phase 4 | Unknown | Second Xiangya Hospital of Central South University | 224 | 2022-07-25 | 2022-08-10 |
| A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy rituximab group - IgA Nephropathy | Phase 4 | Unknown | XIEJINGYUAN | 116 | 2020-06-20 | 2023-04-21 |
| Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis Jinshuibao, Placebo - Chronic Kidney Disease Stage 3B, Chronic Kidney Disease stage4 | Phase 4 | Unknown | Jemincare | 332 | 2020-04-30 | 2020-04-20 |
| Metformin In Prevention of Lupus Nephritis Metformin - Lupus Nephritis | Phase 4 | Unknown | RenJi Hospital | 30 | 2019-11-01 | 2019-10-31 |
| Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency Leflunomide 20 mg+prednisone 0.5mg/kg/d - Glomerulonephritis, IGA, Renal Insufficiency, Chronic | Phase 4 | Unknown | Shenzhen Second People's Hospital | 70 | 2019-09-12 | 2020-02-18 |
| Effect of Immunosuppression in IgA Nephropathy Immunosuppressive treatment, intensive supportive care - Biopsy-proven IgA Nephropathy | Phase 4 | Unknown | Yonsei University | 174 | 2019-03-01 | 2019-02-08 |
| Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis Artesunate, placebo - Lupus Nephritis | Phase 4 | Unknown | Sun Yat-sen University | 90 | 2019-01-16 | 2021-09-23 |
| Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy Mycophenolate Mofetil, Cyclosporins - Idiopathic Membranous Nephropathy | Phase 4 | Unknown | Guangdong Provincial People's Hospital | 128 | 2018-07-01 | 2019-03-18 |
| Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN) Tacrolimus &entecavir, placebo & entecavir - Hepatitis B Virus Associated Nephrotic Syndrome | Phase 4 | Unknown | Guangdong Provincial People's Hospital | 112 | 2017-02-01 | 2017-02-24 |
| Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy prednisone and cyclophosphamide, prednisone alone - IgA Nephropathy | Phase 4 | Unknown | Guangdong Provincial People's Hospital | 133 | 2016-12-01 | 2017-07-17 |
| Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy Hydroxychloroquine Sulfate, Valsartan - Primary IgA Nephropathy | Phase 4 | Unknown | Peking Union Medical College Hospital | 98 | 2016-06-01 | 2017-09-20 |
| Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy Mycophenolate Mofetil, ACE inhibitor, Corticosteroid - IgA Nephropathy | Phase 4 | Unknown | Yonsei University | 100 | 2016-06-01 | 2016-12-05 |
| Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy Losartan, Abelmoschus manihot - IgA Nephropathy | Phase 4 | Unknown | Chen Xiangmei | 1600 | 2014-09-01 | 2016-07-06 |
| Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis Shenyankangfu tablets, Losartan potassium 50mg, Shenyankangfu tablets and Losartan potassium 50mg - Glomerulonephritis, Proteinuria | Phase 4 | Unknown | Chinese PLA General Hospital | 720 | 2014-02-01 | 2015-07-01 |
| Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy prednisone plus cyclophosphamide, Prednisone alone - IgA Nephropathy | Phase 4 | Unknown | Guangdong Provincial People's Hospital | 135 | 2012-12-01 | 2017-07-14 |
| Rituximab in Recurrent IgA Nephropathy Intravenous Rituximab, ACEI/ARB and corticosteroids - Recurrent IgA Nephropathy | Phase 4 | Unknown | Chulalongkorn University | 30 | 2012-01-01 | 2015-10-08 |
Showing 20 of 22. Sign in to see all of them.
Glomerulonephritis, IGA (10) · Lupus Nephritis (5) · Glomerulonephritis (4) · Autoimmune Diseases (2) · Glomerulonephritis, Membranous (2) · Proteinuria (2) · Renal Insufficiency, Chronic (2) · Albuminuria (1) · Camurati-Engelmann Syndrome (1) · Cystitis (1) · Hepatitis B (1) · Hypertension (1) · Immune System Diseases (1) · Kidney Diseases (1)
Female Urogenital Diseases (22) · Female Urogenital Diseases and Pregnancy Complications (22) · Male Urogenital Diseases (22) · Urogenital Diseases (22) · Kidney Diseases (21) · Urologic Diseases (21) · Immune System Diseases (17) · Autoimmune Diseases (16) · Glomerulonephritis (16) · Connective Tissue Diseases (6) · Skin and Connective Tissue Diseases (6) · Pathological Conditions, Signs and Symptoms (5) · Lupus Erythematosus, Systemic (4) · Signs and Symptoms (3)
Mycophenolic Acid (4) · Cyclophosphamide (3) · Prednisone (3) · Adrenal Cortex Hormones (2) · Angiotensin-Converting Enzyme Inhibitors (2) · Glucocorticoids (2) · Losartan (2) · Metformin (2) · Prednisolone (2) · Tacrolimus (2) · Artesunate (1) · Calcitriol (1) · Conservative Treatment (1) · Cyclosporins (1) · Enalapril (1)
Guangdong Provincial People's Hospital (4) · Peking University First Hospital (2) · Yonsei University (2) · Chen Xiangmei (1) · Chinese PLA General Hospital (1) · Chinese SLE Treatment And Research Group (1) · Chulalongkorn University (1) · Jemincare (1) · Kagawa University (1) · Peking Union Medical College Hospital (1) · RenJi Hospital (1) · Second Xiangya Hospital of Central South University (1) · Shenzhen Second People's Hospital (1) · Sun Yat-sen University (1) · Technical University of Munich (1)
China (14) · South Korea (2) · Germany (1) · Japan (1) · Thailand (1)
Lifen Wang, PHD (1) · Lixia Xu, PHD (1) · Lutz Renders, Prof. Dr. med. (1) · Masahito Imanishi (1) · Mengtao Li, MD (1) · Wei Shi, PHD (1) · Wiwat Chancharoenthana, M.D., Ph.D. (1) · Xiangmei Chen, MD.& Ph.D (1) · Xiaochuan Wu (1) · Xinling Liang, PHD (1) · Zhiming Ye, PHD (1)
PMID 38299639, PMID 10093981, PMID 16164651, PMID 17377504, PMID 18930568, PMID 19628647, PMID 20220333, PMID 2023605, PMID 2142748, PMID 21677438, PMID 22371643, PMID 23150796, PMID 23449768, PMID 23689577, PMID 24189358, PMID 24375637, PMID 25480673, PMID 25677392, PMID 26630142, PMID 28395659, PMID 28763548, PMID 33589406, PMID 34778952, PMID 35672893, PMID 38864363